{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T05:48:08Z","timestamp":1774676888534,"version":"3.50.1"},"reference-count":0,"publisher":"Informa UK Limited","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Technology Analysis & Strategic Management"],"published-print":{"date-parts":[[2009,2]]},"DOI":"10.1080\/09537320802625280","type":"journal-article","created":{"date-parts":[[2009,1,15]],"date-time":"2009-01-15T03:52:35Z","timestamp":1231991555000},"page":"195-212","source":"Crossref","is-referenced-by-count":19,"title":["Four scenarios for the future of the pharmaceutical industry"],"prefix":"10.1080","volume":"21","author":[{"given":"Ron","family":"Bradfield","sequence":"first","affiliation":[]},{"given":"Hany","family":"El-Sayed","sequence":"additional","affiliation":[]}],"member":"301","container-title":["Technology Analysis & Strategic Management"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/09537320802625280","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,12,18]],"date-time":"2016-12-18T08:26:42Z","timestamp":1482049602000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.tandfonline.com\/doi\/abs\/10.1080\/09537320802625280"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,2]]}},"alternative-id":["10.1080\/09537320802625280"],"URL":"https:\/\/doi.org\/10.1080\/09537320802625280","relation":{},"ISSN":["0953-7325","1465-3990"],"issn-type":[{"value":"0953-7325","type":"print"},{"value":"1465-3990","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2]]}}}